VivekKumar Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia

VivekKumar
Dr Vivek Kumar is working as Associate Professor of Nephrology at the Postgraduate Institute of Medical Education and Research at Chandigarh in India. His research interests include epidemiology and outcomes in CKD and AKI. He is an India Alliance Clinical and Public Health Intermediate Fellow (Department of Biotechnology, Government of India and Wellcome Trust, UK). He has experience in setting up multi-centric cohort studies and clinical trials in India.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/df14a4fe56ac4ba1d1ec7373db077bfd.jpeg
First Name
Vivek
Last Name
Kumar
Institution
Country.
India

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
SabineKaram Chair sabinejkaram@gmail.comUniversity of MinnesotaUnited States
SourabhSharma Chair Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Best Abstract Winner - Basic Science
  • Best Abstract Winner - Clinical Research
  • Q and A
  • Everything You Ever Wanted to Know About Tropical Infections and the Kidney
    MythriShankar Speaker Institute of NephrourologyIndia
  • Challenges in the Tropics: When CKDu Becomes Less Unknown
    ErangaWijewickrama Speaker Faculty of Medicine, University of ColomboSri Lanka
  • Roundtable Discussion
    BiancaDavidson Speaker Groote Schuur Hospital, University of Cape TownSouth Africa
    ErangaWijewickrama Speaker Faculty of Medicine, University of ColomboSri Lanka
    MythriShankar Speaker Institute of NephrourologyIndia
    SourabhSharma Speaker Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
    VivekKumar Speaker Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia
Champa Hall 304

Saturday, February 8, 2025

Time Session
9:45 a.m.
11:15 a.m.
Hyeong CheonPark Chair amp97nody@gmail.comHyeong Cheon Park, Gangnam Severance Hospital, Yonsei UniversityKorea (Republic of)
  • What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?
    Chi-yuanHsu Speaker University of California, San FranciscoUnited States
  • Are Biomarkers in AKI Ready for Prime Time?
    ChiragParikh Speaker Johns Hopkins University
  • Community-acquired AKI in the Tropics - Is it a Different Disease?
    VivekKumar Speaker Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia
  • Sex as a Biological Variable in the Epidemiology of AKI
    MarliesOstermann Speaker King's College LondonUnited Kingdom
  • Q&A
Amaltas A Hall B101A